- €2.74bn
- €2.99bn
- €958.18m
- 81
- 14
- 94
- 71
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 866 | 891 | 835 | 834 | 958 |
Cost of Revenue | |||||
Gross Profit | 671 | 688 | 638 | 645 | 718 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 643 | 683 | 704 | 717 | 883 |
Operating Profit | 223 | 208 | 130 | 117 | 75.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 229 | 215 | 134 | 118 | 65.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 165 | 155 | 96.1 | 84.3 | 19.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 165 | 155 | 95.7 | 83.9 | 19 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 165 | 155 | 95.7 | 83.9 | 19 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.24 | 2.21 | 1.43 | 1.3 | 0.51 |
Dividends per Share |